Results 141 to 150 of about 92,839 (346)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

HYPNOSIS FOR IMPROVEMENT OF PHYSICAL STRENGTH AND RESISTANCE

Publicaciones, 2014
In this case study we assessed the effectiveness of hypnosis for the physical force in sportsmen. Participant was 1 amateur cyclist with hypnotic suggestion.
Félix Zurita Ortega, Rubén Fernández García, Antonio José Pérez Cortés, Manuel Castro Sánchez   +3 more
doaj  

Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects [PDF]

, 2003
Diederik K. Van Sassenbroeck, Peter De Paepe, Frans M. Belpaire, Paul Boon, Walter Buylaert   +4 more
openalex   +1 more source

Changing trends in drug overdose mortality in Spain, 2001–2022

Addiction, EarlyView.
Abstract Aim To measure the evolution of drug overdose mortality in Spain between 2001 and 2022. Design, Setting, Participants A repeated cross‐sectional observational study using nationwide mortality data from Spain, 2001–2022, among individuals aged 15–64 years.
Florencia Giné, Marta Donat, Juan Miguel Guerras, Gregorio Barrio, María José Belza, Julieta Politi, Enrique Regidor   +6 more
wiley   +1 more source

Hypnotism [PDF]

Archives of The Roentgen Ray, 1890
openaire   +2 more sources

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Hypnotic analgesia and the placebo effect; controlling ischemic pain.

, 1982
Henderikus J. Stam
openalex   +2 more sources

PHARMACOKINETICS OF THE HYPNOTIC BENZODIAZEPINE, TEMAZEPAM [PDF]

, 1979
P. R. M. Bittencourt, A. Richens, P. A. Toseland, J. F. C. Wicks, A. N. Latham   +4 more
openalex   +1 more source

Conor Gearty

The Modern Law Review, EarlyView.
Thomas Poole
wiley   +1 more source

Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024

Addiction, EarlyView.
Abstract Background and aims Gamma‐hydroxybutyrate (GHB) is an endogenous neurochemical and illicit synthetic drug. Its precursors, gamma‐butyrolactone (GBL) and 1,4‐butanediol (1,4‐BD), are often used as substitutes. We aimed to describe GHB‐related harms in New South Wales (NSW), Australia.
Krista J. Siefried, Janette L. Smith, Christine A. Harvey, Anthony Nedanoski, Jared A. Brown, Una Cullinan, Nadine Ezard, Thanjira Jiranantakan, Darren M. Roberts, Jonathan Brett   +9 more
wiley   +1 more source